Prelude Capital Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
13,096
-10,871
| -45% | -$88.3K | 0.01% | 905 |
|
|
2025
Q1 | $169K | Buy |
23,967
+9,381
| +64% | +$66K | 0.01% | 889 |
|
|
2024
Q4 | $108K | Sell |
14,586
-12,918
| -47% | -$96K | 0.01% | 958 |
|
|
2024
Q3 | $136K | Buy |
+27,504
| New | +$136K | 0.01% | 1020 |
|
|
2024
Q1 | – | Sell |
-22,745
| Closed | -$141K | – | 1326 |
|
|
2023
Q4 | $141K | Buy |
+22,745
| New | +$141K | 0.01% | 868 |
|
|
2023
Q2 | – | Sell |
-21,295
| Closed | -$80.4K | – | 1141 |
|
|
2023
Q1 | $80.4K | Buy |
+21,295
| New | +$80.4K | ﹤0.01% | 875 |
|
|
2019
Q4 | – | Sell |
-1,640
| Closed | -$18K | – | 1608 |
|
|
2019
Q3 | $18K | Buy |
1,640
+951
| +138% | +$10.4K | ﹤0.01% | 953 |
|
|
2019
Q2 | $6K | Buy |
+689
| New | +$6K | ﹤0.01% | 1106 |
|
|
2017
Q3 | – | Sell |
-2,300
| Closed | -$34K | – | 1645 |
|
|
2017
Q2 | $34K | Buy |
+2,300
| New | +$34K | ﹤0.01% | 1012 |
|
|
2017
Q1 | – | Sell |
-400
| Closed | -$6K | – | 1574 |
|
|
2016
Q4 | $6K | Buy |
+400
| New | +$6K | ﹤0.01% | 1371 |
|
|
2015
Q4 | – | Sell |
-200
| Closed | -$2K | – | 1497 |
|
|
2015
Q3 | $2K | Sell |
200
-1,400
| -88% | -$14K | ﹤0.01% | 1340 |
|
|
2015
Q2 | $23K | Sell |
1,600
-1,300
| -45% | -$18.7K | ﹤0.01% | 1235 |
|
|
2015
Q1 | $40K | Buy |
+2,900
| New | +$40K | 0.01% | 1373 |
|
|
2014
Q3 | – | Sell |
-15,300
| Closed | -$191K | – | 1871 |
|
|
2014
Q2 | $191K | Buy |
15,300
+900
| +6% | +$11.2K | 0.03% | 665 |
|
|
2014
Q1 | $161K | Sell |
14,400
-5,614
| -28% | -$62.8K | 0.02% | 707 |
|
|
2013
Q4 | $243K | Buy |
20,014
+754
| +4% | +$9.16K | 0.04% | 515 |
|
|
2013
Q3 | $235K | Buy |
+19,260
| New | +$235K | 0.04% | 429 |
|